| Year |
Citation |
Score |
| 2023 |
Zang T, Osei Kuffour E, Baharani VA, Canis M, Schmidt F, Da Silva J, Lercher A, Chaudhary P, Hoffmann HH, Gazumyan A, Miranda IC, MacDonald MR, Rice CM, Nussenzweig MC, Hatziioannou T, et al. Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies. Proceedings of the National Academy of Sciences of the United States of America. 120: e2317367120. PMID 38096415 DOI: 10.1073/pnas.2317367120 |
0.381 |
|
| 2023 |
Zhang F, Schmidt F, Muecksch F, Wang Z, Gazumyan A, Nussenzweig MC, Gaebler C, Caskey M, Hatziioannou T, Bieniasz PD. SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity. Biorxiv : the Preprint Server For Biology. PMID 37425700 DOI: 10.1101/2023.06.30.547241 |
0.312 |
|
| 2023 |
Wang Z, Muecksch F, Raspe R, Johannsen F, Turroja M, Canis M, ElTanbouly MA, Santos GSS, Johnson B, Baharani VA, Patejak R, Yao KH, Chirco BJ, Millard KG, Shimeliovich I, ... Gazumyan A, et al. Memory B cell development elicited by mRNA booster vaccinations in the elderly. The Journal of Experimental Medicine. 220. PMID 37368240 DOI: 10.1084/jem.20230668 |
0.308 |
|
| 2023 |
Gristick HB, Hartweger H, Loewe M, van Schooten J, Ramos V, Oliveira TY, Nishimura Y, Koranda NS, Wall A, Yao KH, Poston D, Gazumyan A, Wiatr M, Horning M, Keeffe JR, et al. CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals. Science Immunology. 8: eade6364. PMID 36763635 DOI: 10.1126/sciimmunol.ade6364 |
0.362 |
|
| 2022 |
Schaefer-Babajew D, Wang Z, Muecksch F, Cho A, Loewe M, Cipolla M, Raspe R, Johnson B, Canis M, DaSilva J, Ramos V, Turroja M, Millard KG, Schmidt F, Witte L, ... ... Gazumyan A, et al. Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination. Nature. PMID 36473496 DOI: 10.1038/s41586-022-05609-w |
0.383 |
|
| 2022 |
Schaefer-Babajew D, Wang Z, Muecksch F, Cho A, Raspe R, Johnson B, Canis M, DaSilva J, Ramos V, Turroja M, Millard KG, Schmidt F, Dizon J, Shimelovich I, Yao KH, ... ... Gazumyan A, et al. Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination. Medrxiv : the Preprint Server For Health Sciences. PMID 35982682 DOI: 10.1101/2022.08.05.22278483 |
0.385 |
|
| 2022 |
Agudelo M, Muecksch F, Schaefer-Babajew D, Cho A, DaSilva J, Bednarski E, Ramos V, Oliveira TY, Cipolla M, Gazumyan A, Zong S, Rodrigues DAS, Lira GS, Conde L, Aguiar RS, et al. Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants. The Journal of Experimental Medicine. 219. PMID 35796685 DOI: 10.1084/jem.20220367 |
0.354 |
|
| 2022 |
Wang Z, Muecksch F, Cho A, Gaebler C, Hoffmann HH, Ramos V, Zong S, Cipolla M, Johnson B, Schmidt F, DaSilva J, Bednarski E, Ben Tanfous T, Raspe R, Yao K, ... ... Gazumyan A, et al. Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins. Immunity. PMID 35447092 DOI: 10.1016/j.immuni.2022.04.003 |
0.385 |
|
| 2022 |
Muecksch F, Wang Z, Cho A, Gaebler C, Ben Tanfous T, DaSilva J, Bednarski E, Ramos V, Zong S, Johnson B, Raspe R, Schaefer-Babajew D, Shimeliovich I, Daga M, Yao KH, ... ... Gazumyan A, et al. Increased Memory B Cell Potency and Breadth After a SARS-CoV-2 mRNA Boost. Nature. PMID 35447027 DOI: 10.1038/s41586-022-04778-y |
0.303 |
|
| 2022 |
Gaebler C, Nogueira L, Stoffel E, Oliveira TY, Breton G, Millard KG, Turroja M, Butler A, Ramos V, Seaman MS, Reeves JD, Petroupoulos CJ, Shimeliovich I, Gazumyan A, Jiang CS, et al. Prolonged viral suppression with anti-HIV-1 antibody therapy. Nature. PMID 35418681 DOI: 10.1038/s41586-022-04597-1 |
0.34 |
|
| 2022 |
Muecksch F, Wang Z, Cho A, Gaebler C, Tanfous TB, DaSilva J, Bednarski E, Ramos V, Zong S, Johnson B, Raspe R, Schaefer-Babajew D, Shimeliovich I, Daga M, Yao KH, ... ... Gazumyan A, et al. Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose. Biorxiv : the Preprint Server For Biology. PMID 35194607 DOI: 10.1101/2022.02.14.480394 |
0.312 |
|
| 2022 |
Wang Z, Muecksch F, Cho A, Gaebler C, Hoffmann HH, Ramos V, Zong S, Cipolla M, Johnson B, Schmidt F, DaSilva J, Bednarski E, Tanfous TB, Raspe R, Yao K, ... ... Gazumyan A, et al. Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins. Biorxiv : the Preprint Server For Biology. PMID 35132412 DOI: 10.1101/2022.02.01.478695 |
0.388 |
|
| 2021 |
Cho A, Muecksch F, Schaefer-Babajew D, Wang Z, Finkin S, Gaebler C, Ramos V, Cipolla M, Mendoza P, Agudelo M, Bednarski E, DaSilva J, Shimeliovich I, Dizon J, Daga M, ... ... Gazumyan A, et al. Anti-SARS-CoV-2 receptor binding domain antibody evolution after mRNA vaccination. Nature. PMID 34619745 DOI: 10.1038/s41586-021-04060-7 |
0.313 |
|
| 2021 |
Muecksch F, Weisblum Y, Barnes CO, Schmidt F, Schaefer-Babajew D, Wang Z, C Lorenzi JC, Flyak AI, DeLaitsch AT, Huey-Tubman KE, Hou S, Schiffer CA, Gaebler C, Da Silva J, Poston D, ... ... Gazumyan A, et al. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity. PMID 34331873 DOI: 10.1016/j.immuni.2021.07.008 |
0.357 |
|
| 2021 |
Wang Z, Muecksch F, Schaefer-Babajew D, Finkin S, Viant C, Gaebler C, Hoffmann HH, Barnes CO, Cipolla M, Ramos V, Oliveira TY, Cho A, Schmidt F, da Silva J, Bednarski E, ... ... Gazumyan A, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. PMID 34126625 DOI: 10.1038/s41586-021-03696-9 |
0.359 |
|
| 2021 |
Wang Z, Muecksch F, Schaefer-Babajew D, Finkin S, Viant C, Gaebler C, Hoffmann HH, Barnes CO, Cipolla M, Ramos V, Oliveira TY, Cho A, Schmidt F, da Silva J, Bednarski E, ... ... Gazumyan A, et al. Naturally enhanced neutralizing breadth to SARS-CoV-2 after one year. Biorxiv : the Preprint Server For Biology. PMID 34100013 DOI: 10.1101/2021.05.07.443175 |
0.353 |
|
| 2021 |
Garber DA, Guenthner P, Mitchell J, Ellis S, Gazumyan A, Nason M, Seaman MS, Mcnicholl JM, Nussenzweig MC, Heneine W. Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virus. Aids (London, England). PMID 33966028 DOI: 10.1097/QAD.0000000000002934 |
0.303 |
|
| 2021 |
Agudelo M, Palus M, Keeffe JR, Bianchini F, Svoboda P, Salát J, Peace A, Gazumyan A, Cipolla M, Kapoor T, Guidetti F, Yao KH, Elsterová J, Teislerová D, Chrdle A, et al. Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease. The Journal of Experimental Medicine. 218. PMID 33831141 DOI: 10.1084/jem.20210236 |
0.386 |
|
| 2021 |
Muecksch F, Weisblum Y, Barnes CO, Schmidt F, Schaefer-Babajew D, Lorenzi JCC, Flyak AI, DeLaitsch AT, Huey-Tubman KE, Hou S, Schiffer CA, Gaebler C, Wang Z, Da Silva J, Poston D, ... ... Gazumyan A, et al. Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies. Biorxiv : the Preprint Server For Biology. PMID 33758864 DOI: 10.1101/2021.03.07.434227 |
0.346 |
|
| 2021 |
Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, Schaefer-Babajew D, Cipolla M, Gaebler C, Lieberman JA, Oliveira TY, Yang Z, Abernathy ME, Huey-Tubman KE, Hurley A, ... ... Gazumyan A, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. PMID 33567448 DOI: 10.1038/s41586-021-03324-6 |
0.37 |
|
| 2021 |
Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, Schaefer-Babajew D, Cipolla M, Gaebler C, Lieberman JA, Yang Z, Abernathy ME, Huey-Tubman KE, Hurley A, Turroja M, ... ... Gazumyan A, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Biorxiv : the Preprint Server For Biology. PMID 33501451 DOI: 10.1101/2021.01.15.426911 |
0.362 |
|
| 2021 |
Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, Cipolla M, Viant C, Barnes CO, Bram Y, Breton G, ... ... Gazumyan A, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. PMID 33461210 DOI: 10.1038/s41586-021-03207-w |
0.373 |
|
| 2021 |
Schäfer A, Muecksch F, Lorenzi JCC, Leist SR, Cipolla M, Bournazos S, Schmidt F, Maison RM, Gazumyan A, Martinez DR, Baric RS, Robbiani DF, Hatziioannou T, Ravetch JV, Bieniasz PD, et al. Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo. The Journal of Experimental Medicine. 218. PMID 33211088 DOI: 10.1084/jem.20201993 |
0.347 |
|
| 2020 |
Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Viant C, Gaebler C, Cipolla M, Hoffmann HH, Oliveira TY, Oren DA, Ramos V, Nogueira L, Michailidis E, Robbiani DF, Gazumyan A, et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Science Translational Medicine. PMID 33288661 DOI: 10.1126/scitranslmed.abf1555 |
0.373 |
|
| 2020 |
Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Ladinsky M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, Cipolla M, Viant C, Barnes CO, Hurley A, ... ... Gazumyan A, et al. Evolution of Antibody Immunity to SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 33173867 DOI: 10.1101/2020.11.03.367391 |
0.373 |
|
| 2020 |
Viant C, Weymar GHJ, Escolano A, Chen S, Hartweger H, Cipolla M, Gazumyan A, Nussenzweig MC. Antibody Affinity Shapes the Choice between Memory and Germinal Center B Cell Fates. Cell. PMID 33125897 DOI: 10.1016/j.cell.2020.09.063 |
0.305 |
|
| 2020 |
Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, Muecksch F, Rutkowska M, Hoffmann HH, Michailidis E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife. 9. PMID 33112236 DOI: 10.7554/eLife.61312 |
0.356 |
|
| 2020 |
Wang Z, Barnes CO, Gautam R, Cetrulo Lorenzi JC, Mayer CT, Oliveira TY, Ramos V, Cipolla M, Gordon KM, Gristick HB, West AP, Nishimura Y, Raina H, Seaman MS, Gazumyan A, et al. A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch. Elife. 9. PMID 33084569 DOI: 10.7554/eLife.61991 |
0.313 |
|
| 2020 |
Schäfer A, Muecksch F, Lorenzi JCC, Leist SR, Cipolla M, Bournazos S, Schmidt F, Gazumyan A, Baric RS, Robbiani DF, Hatziioannou T, Ravetch JV, Bieniasz PD, Nussenzweig MC, Sheahan TP. Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection . Biorxiv : the Preprint Server For Biology. PMID 32995782 DOI: 10.1101/2020.09.15.298067 |
0.353 |
|
| 2020 |
Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Viant C, Gaebler C, Cipolla M, Hoffman HH, Oliveira TY, Oren DA, Ramos V, Nogueira L, Michailidis E, Robbiani DF, Gazumyan A, et al. Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro. Biorxiv : the Preprint Server For Biology. PMID 32935095 DOI: 10.1101/2020.09.09.288555 |
0.361 |
|
| 2020 |
Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JCC, Muecksch F, Rutkowska M, Hoffmann HH, Michailidis E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Biorxiv : the Preprint Server For Biology. PMID 32743579 DOI: 10.1101/2020.07.21.214759 |
0.356 |
|
| 2020 |
Schmidt F, Weisblum Y, Muecksch F, Hoffmann HH, Michailidis E, Lorenzi JCC, Mendoza P, Rutkowska M, Bednarski E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. The Journal of Experimental Medicine. 217. PMID 32692348 DOI: 10.1084/Jem.20201181 |
0.322 |
|
| 2020 |
Schmidt F, Weisblum Y, Muecksch F, Hoffmann HH, Michailidis E, Lorenzi JCC, Mendoza P, Rutkowska M, Bednarski E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. Biorxiv : the Preprint Server For Biology. PMID 32577658 DOI: 10.1101/2020.06.08.140871 |
0.323 |
|
| 2020 |
Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, Agudelo M, Barnes CO, Gazumyan A, Finkin S, Hägglöf T, Oliveira TY, Viant C, Hurley A, Hoffmann HH, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. PMID 32555388 DOI: 10.1038/S41586-020-2456-9 |
0.399 |
|
| 2020 |
Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, Agudelo M, Barnes CO, Gazumyan A, Finkin S, Hagglof T, Oliveira TY, Viant C, Hurley A, Hoffmann HH, et al. Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals. Biorxiv : the Preprint Server For Biology. PMID 32511384 DOI: 10.1101/2020.05.13.092619 |
0.4 |
|
| 2020 |
Wang Q, Michailidis E, Yu Y, Wang Z, Hurley AM, Oren DA, Mayer CT, Gazumyan A, Liu Z, Zhou Y, Schoofs T, Yao KH, Nieke JP, Wu J, Jiang Q, et al. A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations. Cell Host & Microbe. PMID 32504577 DOI: 10.1016/J.Chom.2020.05.010 |
0.316 |
|
| 2020 |
Van Rompay KKA, Coffey LL, Kapoor T, Gazumyan A, Keesler RI, Jurado A, Peace A, Agudelo M, Watanabe J, Usachenko J, Singapuri A, Immareddy R, Ardeshir A, Stuart JB, Bournazos S, et al. A combination of two human monoclonal antibodies limits fetal damage by Zika virus in macaques. Proceedings of the National Academy of Sciences of the United States of America. PMID 32209664 DOI: 10.1073/Pnas.2000414117 |
0.331 |
|
| 2019 |
Wang Z, Merkenschlager J, Chen ST, Oliveira TY, Ramos V, Gordon KM, Yao KH, Jankovic M, Gazumyan A, Nussenzweig M, Escolano A. Isolation of single HIV-1 Envelope specific B cells and antibody cloning from immunized rhesus macaques. Journal of Immunological Methods. 112734. PMID 31866284 DOI: 10.1016/J.Jim.2019.112734 |
0.41 |
|
| 2019 |
Escolano A, Gristick HB, Abernathy ME, Merkenschlager J, Gautam R, Oliveira TY, Pai J, West AP, Barnes CO, Cohen AA, Wang H, Golijanin J, Yost D, Keeffe JR, Wang Z, ... ... Gazumyan A, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. PMID 31142836 DOI: 10.1038/S41586-019-1250-Z |
0.404 |
|
| 2019 |
Hartweger H, McGuire AT, Horning M, Taylor JJ, Dosenovic P, Yost D, Gazumyan A, Seaman MS, Stamatatos L, Jankovic M, Nussenzweig MC. HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells. The Journal of Experimental Medicine. PMID 30975893 DOI: 10.1084/Jem.20190287 |
0.335 |
|
| 2018 |
Keeffe JR, Van Rompay KKA, Olsen PC, Wang Q, Gazumyan A, Azzopardi SA, Schaefer-Babajew D, Lee YE, Stuart JB, Singapuri A, Watanabe J, Usachenko J, Ardeshir A, Saeed M, Agudelo M, et al. A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates. Cell Reports. 25: 1385-1394.e7. PMID 30403995 DOI: 10.1016/J.Celrep.2018.10.031 |
0.351 |
|
| 2018 |
Gautam R, Nishimura Y, Gaughan N, Gazumyan A, Schoofs T, Buckler-White A, Seaman MS, Swihart BJ, Follmann DA, Nussenzweig MC, Martin MA. A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection. Nature Medicine. PMID 29662199 DOI: 10.1038/S41591-018-0001-2 |
0.384 |
|
| 2017 |
Horwitz JA, Bar-On Y, Lu CL, Fera D, Lockhart AAK, Lorenzi JCC, Nogueira L, Golijanin J, Scheid JF, Seaman MS, Gazumyan A, Zolla-Pazner S, Nussenzweig MC. Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo. Cell. PMID 28757252 DOI: 10.1016/J.Cell.2017.06.048 |
0.316 |
|
| 2017 |
Robbiani DF, Bozzacco L, Keeffe JR, Khouri R, Olsen PC, Gazumyan A, Schaefer-Babajew D, Avila-Rios S, Nogueira L, Patel R, Azzopardi SA, Uhl LFK, Saeed M, Sevilla-Reyes EE, Agudelo M, et al. Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico. Cell. 169: 597-609.e11. PMID 28475892 DOI: 10.1016/J.Cell.2017.04.024 |
0.375 |
|
| 2016 |
von Boehmer L, Liu C, Ackerman S, Gitlin AD, Wang Q, Gazumyan A, Nussenzweig MC. Sequencing and cloning of antigen-specific antibodies from mouse memory B cells. Nature Protocols. 11: 1908-1923. PMID 27658009 DOI: 10.1038/Nprot.2016.102 |
0.375 |
|
| 2016 |
Escolano A, Steichen JM, Dosenovic P, Kulp DW, Golijanin J, Sok D, Freund NT, Gitlin AD, Oliveira T, Araki T, Lowe S, Chen ST, Heinemann J, Yao KH, Georgeson E, ... ... Gazumyan A, et al. Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice. Cell. 166: 1445-1458.e12. PMID 27610569 DOI: 10.1016/J.Cell.2016.07.030 |
0.371 |
|
| 2016 |
Bournazos S, Gazumyan A, Seaman MS, Nussenzweig MC, Ravetch JV. Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency. Cell. 165: 1609-20. PMID 27315478 DOI: 10.1016/J.Cell.2016.04.050 |
0.319 |
|
| 2016 |
Lu CL, Murakowski DK, Bournazos S, Schoofs T, Sarkar D, Halper-Stromberg A, Horwitz JA, Nogueira L, Golijanin J, Gazumyan A, Ravetch JV, Caskey M, Chakraborty AK, Nussenzweig MC. Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo. Science (New York, N.Y.). 352: 1001-4. PMID 27199430 DOI: 10.1126/Science.Aaf1279 |
0.32 |
|
| 2016 |
Gautam R, Nishimura Y, Pegu A, Nason MC, Klein F, Gazumyan A, Golijanin J, Buckler-White A, Sadjadpour R, Wang K, Mankoff Z, Schmidt SD, Lifson JD, Mascola JR, Nussenzweig MC, et al. A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Nature. PMID 27120156 DOI: 10.1038/Nature17677 |
0.341 |
|
| 2016 |
Gitlin AD, von Boehmer L, Gazumyan A, Shulman Z, Oliveira TY, Nussenzweig MC. Independent Roles of Switching and Hypermutation in the Development and Persistence of B Lymphocyte Memory. Immunity. PMID 26944202 DOI: 10.1016/J.Immuni.2016.01.011 |
0.311 |
|
| 2015 |
Freund NT, Horwitz JA, Nogueira L, Sievers SA, Scharf L, Scheid JF, Gazumyan A, Liu C, Velinzon K, Goldenthal A, Sanders RW, Moore JP, Bjorkman PJ, Seaman MS, Walker BD, et al. A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo. Plos Pathogens. 11: e1005238. PMID 26516768 DOI: 10.1371/Journal.Ppat.1005238 |
0.342 |
|
| 2015 |
Dosenovic P, von Boehmer L, Escolano A, Jardine J, Freund NT, Gitlin AD, McGuire AT, Kulp DW, Oliveira T, Scharf L, Pietzsch J, Gray MD, Cupo A, van Gils MJ, Yao KH, ... ... Gazumyan A, et al. Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice. Cell. 161: 1505-15. PMID 26091035 DOI: 10.1016/J.Cell.2015.06.003 |
0.382 |
|
| 2015 |
Kong R, Louder MK, Wagh K, Bailer RT, deCamp A, Greene K, Gao H, Taft JD, Gazumyan A, Liu C, Nussenzweig MC, Korber B, Montefiori DC, Mascola JR. Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes. Journal of Virology. 89: 2659-71. PMID 25520506 DOI: 10.1128/Jvi.03136-14 |
0.347 |
|
| 2014 |
Klein F, Nogueira L, Nishimura Y, Phad G, West AP, Halper-Stromberg A, Horwitz JA, Gazumyan A, Liu C, Eisenreich TR, Lehmann C, Fätkenheuer G, Williams C, Shingai M, Martin MA, et al. Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants. The Journal of Experimental Medicine. 211: 2361-72. PMID 25385756 DOI: 10.1084/Jem.20141050 |
0.345 |
|
| 2014 |
Shingai M, Donau OK, Plishka RJ, Buckler-White A, Mascola JR, Nabel GJ, Nason MC, Montefiori D, Moldt B, Poignard P, Diskin R, Bjorkman PJ, Eckhaus MA, Klein F, Mouquet H, ... ... Gazumyan A, et al. Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques. The Journal of Experimental Medicine. 211: 2061-74. PMID 25155019 DOI: 10.1084/Jem.20132494 |
0.357 |
|
| Show low-probability matches. |